3-7482355-G-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_181874.3(GRM7):​c.1515+20633G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.404 in 151,962 control chromosomes in the GnomAD database, including 13,788 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.40 ( 13788 hom., cov: 32)

Consequence

GRM7
NM_181874.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.542

Publications

12 publications found
Variant links:
Genes affected
GRM7 (HGNC:4599): (glutamate metabotropic receptor 7) L-glutamate is the major excitatory neurotransmitter in the central nervous system, and it activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors that have been divided into three groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5, and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3, while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2009]
GRM7 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with seizures, hypotonia, and brain imaging abnormalities
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.605 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_181874.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRM7
NM_000844.4
MANE Select
c.1515+20633G>C
intron
N/ANP_000835.1
GRM7
NM_181874.3
c.1515+20633G>C
intron
N/ANP_870989.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRM7
ENST00000357716.9
TSL:1 MANE Select
c.1515+20633G>C
intron
N/AENSP00000350348.4
GRM7
ENST00000389336.8
TSL:1
c.1515+20633G>C
intron
N/AENSP00000373987.4
GRM7
ENST00000389335.7
TSL:1
n.1515+20633G>C
intron
N/AENSP00000373986.3

Frequencies

GnomAD3 genomes
AF:
0.404
AC:
61376
AN:
151842
Hom.:
13757
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.611
Gnomad AMI
AF:
0.262
Gnomad AMR
AF:
0.345
Gnomad ASJ
AF:
0.292
Gnomad EAS
AF:
0.413
Gnomad SAS
AF:
0.338
Gnomad FIN
AF:
0.345
Gnomad MID
AF:
0.322
Gnomad NFE
AF:
0.314
Gnomad OTH
AF:
0.366
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.404
AC:
61459
AN:
151962
Hom.:
13788
Cov.:
32
AF XY:
0.403
AC XY:
29901
AN XY:
74256
show subpopulations
African (AFR)
AF:
0.611
AC:
25325
AN:
41454
American (AMR)
AF:
0.345
AC:
5266
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.292
AC:
1014
AN:
3470
East Asian (EAS)
AF:
0.413
AC:
2128
AN:
5158
South Asian (SAS)
AF:
0.337
AC:
1624
AN:
4812
European-Finnish (FIN)
AF:
0.345
AC:
3632
AN:
10542
Middle Eastern (MID)
AF:
0.333
AC:
98
AN:
294
European-Non Finnish (NFE)
AF:
0.314
AC:
21364
AN:
67942
Other (OTH)
AF:
0.365
AC:
770
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1779
3557
5336
7114
8893
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
562
1124
1686
2248
2810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.373
Hom.:
1421
Bravo
AF:
0.413
Asia WGS
AF:
0.381
AC:
1326
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
1.9
DANN
Benign
0.65
PhyloP100
-0.54
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs779706; hg19: chr3-7524042; API